Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H25NO.ClH |
| Molecular Weight | 295.847 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCCCCC(N1CCCC1)C(=O)C2=CC=CC=C2
InChI
InChIKey=WHQOZXALFDXFRH-UHFFFAOYSA-N
InChI=1S/C17H25NO.ClH/c1-2-3-5-12-16(18-13-8-9-14-18)17(19)15-10-6-4-7-11-15;/h4,6-7,10-11,16H,2-3,5,8-9,12-14H2,1H3;1H
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | C17H25NO |
| Molecular Weight | 259.3865 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, α-PHPP and α-POP, with 11 newly distributed designer drugs in illegal products". | 2015 Jun |
|
| Metabolism of α-PHP and α-PHPP in humans and the effects of alkyl chain lengths on the metabolism of α-pyrrolidinophenone-type designer drugs. | 2018 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 10:36:31 GMT 2023
by
admin
on
Sat Dec 16 10:36:31 GMT 2023
|
| Record UNII |
WP3PRZ4IAZ
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
HEPTANOPHENONE, 2-(1-PYRROLIDINYL)-, HYDROCHLORIDE
Created by
admin on Sat Dec 16 10:36:31 GMT 2023 , Edited by admin on Sat Dec 16 10:36:31 GMT 2023
|
PRIMARY | α-Pyrrolidinopentiophenone (α-PVP) is an analog of pyrovalerone, a psychoactive compound that is regulated as Schedule V in the United States. Pyrrolidinophenone-derived designer drugs, like α-PVP, are emerging drugs of interest.1,2 PV8 (hydrochloride) differs from α-PVP by having heptaphenone in place of the pentiophenone portion of the compound. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications. | ||
|
13415-55-9
Created by
admin on Sat Dec 16 10:36:31 GMT 2023 , Edited by admin on Sat Dec 16 10:36:31 GMT 2023
|
PRIMARY | |||
|
129844528
Created by
admin on Sat Dec 16 10:36:31 GMT 2023 , Edited by admin on Sat Dec 16 10:36:31 GMT 2023
|
PRIMARY | |||
|
WP3PRZ4IAZ
Created by
admin on Sat Dec 16 10:36:31 GMT 2023 , Edited by admin on Sat Dec 16 10:36:31 GMT 2023
|
PRIMARY | |||
|
DTXSID801336959
Created by
admin on Sat Dec 16 10:36:31 GMT 2023 , Edited by admin on Sat Dec 16 10:36:31 GMT 2023
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
SALT/SOLVATE -> PARENT |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |